Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525420 · ClinicalTrials.gov registry record · NA
Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT01525420: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT01525420 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525420, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT). Implementation outcomes: * end of treatment and 6-month follow-up data retention rates; * intervention implementation quality; * number \& length of calls completed. Comparison of each arm's implementation
Primary Outcome
30-Day point prevalence abstinence at 6 months post treatment
Interventions
- OTHER Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Acceptance Therapy (ACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01525420 record still lists
NCT01525420 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT01525420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01525420 about?
NCT01525420 is a clinical study titled "Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy". The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT). Implementation outcomes: * end of treatment and 6-month follow-up data retention rates; * intervention implementation...
What is the current status of trial NCT01525420?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2012-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01525420?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (OTHER), Acceptance Therapy (ACT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01525420?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01525420's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia